Yahoo Web Search

Search results

1. www.editasmedicine.comEditas Medicine

   www.editasmedicine.com

   • Cached

   Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.

   • Research and Pipeline

     Editas Medicine works with two distinct CRISPR nucleases:...

   • Join Our Team

     At Editas Medicine, we know that our greatest strength comes...

   • Newsroom

     EDITAS MEDICINE’S NEWSROOM Editas Medicine is a leading gene...

   • Investors

     Editas Medicine to Present Clinical Data from the RUBY and...

   • About Editas Medicine Learn More About Editas Medicine, The Work We Do, and The Team That Makes Everything Possible

     Editas Medicine is a clinical stage genome editing company...

   • Contact Us

     BOULDER, CO 4909 Nautilus Court North Suite 208/211 Boulder,...

   • CRISPR Gene Editing

     Editas Medicine is a leading gene editing company dedicated...

   • For Patients

     The Editas Medicine Commitment. Engage regularly – seek out...

2. People also ask

   What is Editas Medicine?

   • That is the question we ask ourselves at Editas Medicine. At Editas Medicine, we are pioneering the possible. Our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world.

   Editas Medicine

   www.editasmedicine.com/

   See all results for this question

   Is Editas a CRISPR/Cas9 gene editing company?

   • CAMBRIDGE, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced clinical data from the Phase 1/2 BRILLIANCE trial of EDIT-101, an in vivo CRISPR/Cas9 genome editing medicine in a Company-sponsored webinar.

   Editas Medicine Announces Clinical Data Demonstrating Proof of Concept

   ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-clinical-data-demonstrating-proof

   See all results for this question

   Is Editas Medicine a Biotech stock?

   • The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts. Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?

   Editas Medicine, Inc. (EDIT) - Yahoo Finance

   finance.yahoo.com/quote/EDIT/

   See all results for this question

   Who is the CEO of Editas Therapeutics?

   • Gilmore O'Neill, former CMO of Sarepta Therapeutics, became CEO on June 1, 2022, with Mullen staying on as executive chairman of the board. Editas works with two different CRISPR nucleases, Cas9 and Cas12a. EDIT-101 is a CRISPR based gene therapy for treatment of Leber congenital amaurosis, which is currently in clinical trials.

   Editas Medicine - Wikipedia

   en.wikipedia.org/wiki/Editas_Medicine

   See all results for this question

3. en.wikipedia.org › wiki › Editas_MedicineEditas Medicine - Wikipedia

   en.wikipedia.org › wiki › Editas_Medicine

   • Cached

   Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. History

4. Videos

   • 

     14:44

     youtube.com

     Editas Medicine

     Oct 24, 2016

     2.3K Views

   • 

     14:21

     youtube.com

     Editas Medicine

     Oct 22, 2015

     568 Views

   • 

     48:42

     youtube.com

     Vic Myer - Editas Medicine - Creating a novel class of genome editing therapeutics

     Sep 21, 2015

     876 Views

   View all

5. www.editasmedicine.com › aboutWho We Are | Editas Medicine

   www.editasmedicine.com › about

   • Cached

   Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.

6. www.editasmedicine.com › crispr-gene-CRISPR Gene Editing | Editas Medicine

   www.editasmedicine.com › crispr-gene-

   • Cached

   Editas Medicine is a leading gene editing company dedicated to developing a robust pipeline of medicines to treat people living with serious diseases around the world. We have built a platform that utilizes CRISPR gene editing, a revolutionary approach to developing medicines.

7. finance.yahoo.com › quote › EDITEditas Medicine, Inc. (EDIT) Stock Price, News, Quote ...

   finance.yahoo.com › quote › EDIT

   • Cached

   Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene...

8. finance.yahoo.com › news › editas-medicine-grantedEditas Medicine Granted FDA Regenerative Medicine Advanced ...

   finance.yahoo.com › news › editas-medicine-granted

   • Cached

   Oct 16, 2023 · Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.

9. ir.editasmedicine.com › news-releases › news-releaseEditas Medicine Announces Clinical Data Demonstrating Proof ...

   ir.editasmedicine.com › news-releases › news-release

   • Cached

   Nov 17, 2022 · As a clinical stage genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world.